|

In Vivo Real-time Detection of Circulating Melanoma Cells

RECRUITINGSponsored by University of Arkansas
Actively Recruiting
SponsorUniversity of Arkansas
Started2013-02
Est. completion2026-07
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT01776905

Summary

The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 18 to 80 years
* Histological documented diagnosis of melanoma
* Signed informed consent form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB)
* Must be able to sit still for 90 minutes

Exclusion Criteria:

* Active infection
* Current and significant medical or surgical condition as determined by the Investigator
* Diagnosis or evidence of organic brain syndrome
* Pregnancy or breastfeeding

Conditions2

CancerMelanoma

Locations1 site

University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
Jumin Sunde, MD501-603-1214JSunde2@uams.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.